Literature DB >> 1328043

Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells.

K E Van Vliet1, L A De Graaf-Miltenburg, J Verhoef, J A Van Strijp.   

Abstract

Cells infected with herpes simplex virus type 1 (HSV-1) express a cell-surface receptor able to bind the Fc portion of immunoglobulin G (IgG). In this study we provide direct evidence that bipolar bridging of antibodies, bound to the surface antigens on HSV-infected cells and to the Fc-receptor through the Fc part, offers the virus a survival advantage. Evidence was obtained by comparing the binding of FITC-labelled protein A, which has a similar binding site on IgG as the HSV-FcR, to cell-bound antibodies on HSV-infected cells and non-infected cells. The effectiveness of antibody bipolar bridging was dependent on the concentration of cell-bound IgG. At low concentrations of serum (0.1%) an 80% reduction in protein A-FITC binding to HSV-infected cells compared to non-infected cells was found. Even at higher concentrations of serum, antibody bipolar bridging resulted in a 40% reduction in the number of 'free' available Fc parts on HSV-infected cells compared to non-infected cells. Furthermore, these findings could be confirmed in a functional assay. The Fc-mediated attachment of granulocytes was significantly lower in HSV-infected cells compared to non-infected cells. From this study we conclude that HSV-FcR, by binding immune IgG in a bipolar fashion, provides the virus with an effective defence mechanism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328043      PMCID: PMC1421581     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Fc gamma receptor-mediated interplatelet activation by a monoclonal antibody against beta 2 microglobulin.

Authors:  E Rubinstein; C Boucheix; I Urso; R C Carroll
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

2.  IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: role for neutralization and Fc-dependent functions but not C' cytolysis and C5 chemotaxis.

Authors:  R R McKendall
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

3.  Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function.

Authors:  P M Guyre; R F Graziano; B A Vance; P M Morganelli; M W Fanger
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

4.  H-2 antigens, on mast cell membrane, as target antigens for anaphylactic degranulation.

Authors:  M Daëron; G A Voisin
Journal:  Cell Immunol       Date:  1978-05       Impact factor: 4.868

5.  Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.

Authors:  K P Van Kessel; H J Van Kats-Renaud; J A Van Strijp; M R Visser; J Verhoef
Journal:  J Immunol Methods       Date:  1986-04-03       Impact factor: 2.303

6.  Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes.

Authors:  G Dubin; I Frank; H M Friedman
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1.

Authors:  S Bell; M Cranage; L Borysiewicz; T Minson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

Authors:  I Frank; H M Friedman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Herpes simplex virus glycoprotein C is a receptor for complement component iC3b.

Authors:  R Tal-Singer; C Seidel-Dugan; L Fries; H P Huemer; R J Eisenberg; G H Cohen; H M Friedman
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

10.  Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI.

Authors:  D C Johnson; M C Frame; M W Ligas; A M Cross; N D Stow
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

View more
  16 in total

Review 1.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

Review 2.  Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.

Authors:  Evelyn A Kurt-Jones; Megan H Orzalli; David M Knipe
Journal:  Adv Anat Embryol Cell Biol       Date:  2017       Impact factor: 1.231

Review 3.  Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.

Authors:  L Jacobs
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Biosynthesis of glycoproteins E and I of feline herpesvirus: gE-gI interaction is required for intracellular transport.

Authors:  J D Mijnes; L M van der Horst; E van Anken; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.

Authors:  Lauren M Hook; John M Lubinski; Ming Jiang; Michael K Pangburn; Harvey M Friedman
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.

Authors:  John M Lubinski; Helen M Lazear; Sita Awasthi; Fushan Wang; Harvey M Friedman
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

7.  In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.

Authors:  T Nagashunmugam; J Lubinski; L Wang; L T Goldstein; B S Weeks; P Sundaresan; E H Kang; G Dubin; H M Friedman
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Characterization of Antibody Bipolar Bridging Mediated by the Human Cytomegalovirus Fc Receptor gp68.

Authors:  Blaise Ndjamen; Devashish S Joshi; Scott E Fraser; Pamela J Bjorkman
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

9.  The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G.

Authors:  Elizabeth R Sprague; Henrike Reinhard; Evelyn J Cheung; Alexander H Farley; Robin Deis Trujillo; Hartmut Hengel; Pamela J Bjorkman
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

10.  The disulfide-bonded structure of feline herpesvirus glycoprotein I.

Authors:  J D Mijnes; B C Lutters; A C Vlot; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.